People facing a new diagnosis of cancer are unsettled by their prognosis and treatment options, and they often seek to integrate complementary modalities into their conventional care plan, hoping to improve their chances of cure and decrease side effects. Many do so without informing their oncologist, for fear of alienating them or not convinced that their physician would be informed about complementary therapies. Integrative Oncology, the first volume in the Weil Integrative Medicine Library, provides a wealth of information for both practitioners and consumers on the emerging field of integrative oncology. Noted oncologist Donald Abrams and integrative medicine pioneer Andrew Weil and their international panel of experts present up-to-date and extensively referenced chapters on a wide spectrum of issues and challenges, bound in one comprehensive, reader-friendly text in a format featuring key points, sidebars, tables, and a two-color design for ease of use. It is destined to emerge as the definitive resource in this emerging field.

[Set this out as the head text for all for titles] Before his death at age 91, Dr Abram Hoffer published more than 20 books and 500 research papers on clinical nutrition, chiefly on the therapeutic effect of vitamin B-3 and vitamin C. The four most influential of his studies are now available in professional editions, casebound and jacketed, with reference lists and indexes. These titles are essential acquisitions for medical libraries and the foundation of further research in the therapeutic value of clinical nutrition. HEALING CANCER Written in collaboration with his friend and colleague Linus Pauling, Dr Abram Hoffer presents the results of his nutritional or orthomolecular treatment of hundreds of patients suffering from various forms of cancer. These results show that megadoses of vitamin C and other nutrients are not only highly effective for reversing the progress of this disease in many cases but also for improving the quality of life in others. Healing Cancer not only refutes critics of megavitamin treatment for cancer through the evidence of Dr Hoffer's case studies and Dr Pauling's statistical analysis, but, more importantly, offers new hope to cancer patients for surviving this disease.